Through the Research Strategic Initiative, UAB is investing in cutting-edge technology that accelerates our ability to remain at the forefront of innovation and improve lives across Alabama and beyond ...

This insight explores the $1.1B primary cell market, highlighting how leaders like Lonza, Thermo Fisher, Cloud-Clone, ...

Allied Market Research published a report, titled, "Medical Scrubs Market by Type (Medical Uniforms and Nursing Scrubs), ...

Allied Market Research published a report, titled, "Allergy Immunotherapy Market by Type (Subcutaneous Immunotherapy and ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...

STEMart announces the expansion of its genetic toxicology capabilities with the In Vivo Rat Micronucleus Test services.

CareDx CDNA recently announced clinical validation data supporting AlloHeme, its next-generation, blood-based monitoring test designed to predict relapses in patients with acute myeloid leukemia (AML) ...

Iberdomide has the potential to be the first approved CELMoD agentThe U.S. FDA has granted Breakthrough Therapy Designation and Priority Review for this indication and assigned a target action date of ...

The successful clinical validation of AlloHeme represents a key milestone in CareDx's Transplant+ strategy, expanding the Company's precision medicine capabilities into cell therapy, hematology, and ...

This study reports an important and novel finding that TENT5A, an enzyme involved in fine-tuning poly(A) tail length on selected mRNAs, is required for proper enamel mineralization in mice. The ...

In this webinar, Jorge López, MSc, Flow Cytometry and Hematology Specialist, will discuss the implementation of PIDOT within a Next Generation Flow™ cytometry framework as a sta ...